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Abstract: A new approach to in vivo biosensor design is introduced, based 
on the use of an implantable micron-sized retroreflector-based platform and 
non-invasive  imaging  of  its  surface  reflectivity  by  Optical  Coherence 
Tomography (OCT). The possibility of using OCT for the depth-resolved 
imaging  and  detection  of  micro-retroreflectors  in  highly  turbid  media, 
including  tissue,  is  demonstrated.  The  maximum  imaging  depth  for  the 
detection of the micro-retroreflector-based platform within the surrounding 
media was found to be 0.91 mm for porcine tissue and 1.65 mm for whole 
milk.  With  further  development,  it  may  be  possible  to  utilize  OCT  and 
micro-retroreflectors as a tool for continuous monitoring of analytes in the 
subcutaneous tissue. 
© 2010 Optics Society of America 
OCIS  codes:  (110.4500)  Optical  coherence  tomography;  (170.4500)  Optical  coherence 
tomography;  (170.4580)  Optical  diagnostics  for  medicine;  (280.4788)  Optical  sensing  and 
sensors. 
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1. Introduction 
A broad range of biosensors are used today in clinical applications, ranging from glucose 
monitoring  in  diabetic  patients  [1–6],  to  pathogen  detection  [7,8],  and  to  drug  and  toxic 
metabolite detection in tissues [9–12]. Most applications do not require recurrent monitoring 
of  specific  analytes,  and  these  measurements  can  be  performed  in  vitro.  However  for 
monitoring  of,  e.g.,  glucose  levels,  it  is  desirable  to  make  frequent  (or  even  continuous) 
measurements. A practice recommended by the American Diabetes Association for diabetic 
patient evaluation is to monitor blood glucose levels 3-4 times daily for type I diabetics and 
once each day for type II diabetics [13]. Such monitoring can be difficult and uncomfortable 
for the patient because most methods for monitoring blood glucose levels require puncturing 
of the skin. Thus, it is important to develop alternate approaches that would make it easier and 
less painful for patients to monitor frequently their vital analytes. 
Usually, biosensors require contact between an analyte-sensitive biological element and 
the tissue for the creation of a measurable signal. The development of implantable biosensors 
can avoid the aforementioned disadvantage of skin puncturing by providing potentially non-
invasive monitoring of the analyte of interest. A sub-millimeter-sized implantable biosensor 
platform  can  be  placed  within  the  hypodermis  (the  subcutaneous  tissue),  which  would 
minimize  the  discomfort  associated  with  daily  readings.  Utilizing  such  small  implantable 
biosensors in the subcutaneous tissue would allow access to the dermis and sub-dermis tissue 
layers, which contain many analytes of interest (e.g., glucose). 
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(ConA)-dextran system which, unlike glucose-oxidase-based sensors, is independent of local 
oxygen  levels  [14–16].  For  our  envisioned  retroreflector-based  biosensor,  we  plan  to 
immobilize ConA or other glucose binding agents, such as boronate, onto the implantable 
biosensor surface and allow dextran-coated gold nanoparticles to assemble onto the biosensor 
surface.  The  presence  of  glucose  will  induce  the  dissociation  of  the  dextran-coated  gold 
nanoparticles from the ConA-coated surface and increase reflectivity of the surface. More 
importantly, changes in glucose levels will induce changes in the reflectivity of the biosensor 
surface  due  to  the  light  scattering  caused  by  the  presence  of  gold  nanoparticles.  In  this 
approach,  an  imaging  technique  must  be  used  that  is  capable  of  resolving  retroreflectors 
implanted  in  subcutaneous  tissue,  and  reliably  measuring  the  reflectivity  of  the  biosensor 
surface, which signals the glucose concentration. 
Towards this goal, we have recently developed a highly reflective, micro-retroreflector-
based substrate as a platform for the biosensor. This design includes an array of micron-sized 
retroreflectors  (micro-retroreflectors)  fabricated  on  a  silicon  substrate.  Retroreflectors  are 
unlike planar mirrors, which only return maximum light directly back to the source if the 
mirror is perpendicular to the wave front. In contrast, retroreflectors reflect incident light in an 
anti-parallel manner directly back to its source for a wide range of angles without the need for 
precise alignment. Retroreflectors exist in the form of linear retroreflectors, prisms (or corner 
cubes), spheres, and cat’s eye retroreflectors [17–22], most of which have to date only been 
fabricated in the form of reflective sheets for use in road signs, vehicle reflectors, and safety 
clothing. For this study, simple linear micro-retroreflectors were used, as schematically shown 
in Fig. 1. 
 
Fig.  1.  Linear  micro-retroreflector:  two  reflecting  surfaces  where  incident  light  is  always 
directed back to the source in an anti-parallel manner. 
Development of the biosensor platform requires an imaging technique capable of receiving 
depth-resolved  reflections  from  the  micro-retroreflector-based  platform  surface  as  well  as 
achieving  high  spatial  resolution  for  detection  of  multiple  micro-retroreflectors  in  tissue. 
Conventional imaging modalities such as magnetic resonance imaging, ultrasound, and X-ray 
imaging are capable of imaging structures within tissue, but these modalities lack the high 
spatial  resolution  and/or  potential  analyte-responsiveness  required  for  our  application  of 
detecting micro-retroreflectors within tissue. 
In this study, therefore, we investigated the use of Optical Coherence Tomography (OCT) 
[23], a non-invasive and depth-resolved imaging technique, for reflectance measurements of 
micro-retroreflectors  in  the  subcutaneous  tissue.  OCT  has  high  transverse  resolution  (<10 
µm), which allows for the visualization of individual micro-retroreflectors in tissue, high SNR 
(up to 120 dB) for the precise detection of optical signals when returning from tissue, high in-
depth resolution (~10 µm), and several millimeters of depth penetration in order to image 
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beam interferometer is used to obtain depth-profiled information on the sample of interest 
within  the  coherence  length  of  the  laser.  A  beam  from  a  broadband  low-coherence  laser 
source is split into the reference and sample arms of the interferometer. The backscattered 
light from the sample is recombined with the back-reflected light from the reference arm, 
resulting in the formation of interference fringes, which are captured by an optical sensor. 
OCT methods can be divided into two classes, Time Domain (TD-OCT) and Fourier Domain 
(FD-OCT), which is further split into Swept Source OCT (SS-OCT) and Spectral Domain 
OCT (SD-OCT). In TD-OCT, a scanning reference arm mirror is used, whereas in FD-OCT 
the reference arm mirror is fixed. In SD-OCT, a broadband laser source, and a spectrometer 
with a line camera are used, while in SS-OCT, a swept laser source and photodetector(s) are 
used. In SS-OCT, an in-depth profile (1D, known as an A-scan) of the sample is obtained by 
performing  discrete  Fourier  transform  on  the  acquired  fringes  recorded  by  the 
photodetector(s). Galvanometer mirrors added to the sample arm can be used to construct 2D 
(B-scan) and 3D (C-scan) images of the sample. 
The optical properties of skin can vary significantly among individuals and over time, 
posing  a  challenge  for  absolute  analyte  level  measurements.  Thus,  for  the  envisioned 
implantable glucose sensing biosensor, the micro-retroreflector-based platform must be self-
calibrating. For example, one micro-retroreflector can be an analyte-responsive assay reflector 
while  the  remaining  surrounding  micro-retroreflectors  can  act  as  “always-on”  reference 
reflectors, allowing for accurate determination of reflectivity reduction. Another requirement 
for the prospective implantable glucose sensing biosensor is the ability to detect and measure 
the signal in an automated regime. The unique and complex micro-retroreflector structures 
can  act  as  an  easily  recognizable  pattern  when  submerged  in  tissue.  This  approach  will 
significantly  simplify  the  future  development  of  home  products  for  blood  glucose 
measurements. 
In  this  paper,  we  report  the  first  phase  of  creating  such  a  biosensor  that  includes  the 
development of the implantable solid platform, the employment of an imaging modality to 
detect and visualize the entire retroreflector pattern, and to monitor its reflectance in varying 
depths of highly scattering media, such as skin. For future phases of this study, we plan to 
integrate the necessary chemistry for the detection of specific analytes, such as glucose. 
2. Materials and methods 
2.1 Experimental setup 
Figure 2 shows a schematic of a customized swept-source OCT (SS-OCT) system used in this 
study (based on Thorlabs SL1325, Newton, New Jersey, USA). A broadband swept-source 
laser with a wavelength of 1325 ± 50 nm and an output power of 12 mW was used as the 
optical source in this system. The A-line scanning rate was 16 kHz. The SS-OCT system was 
based on a Mach-Zehnder interferometer (MZI) where 10% of the power was directed to the 
reference  arm  and  90%  to  the  sample  arm.  The  interference  fringes  were  detected  by  a 
balanced photodetector (Thorlabs PDB140C), which was used to remove the common mode 
noise, digitized using a 14-bit ADC (AlazarTech ATS460), and recalibrated using an MZI 
clock signal (MZI, Thorlabs INT-MZI-1300), which provided a frequency clock for the laser. 
The acquired images were 512 × 512 pixels. In-depth scanning was up to 3 mm (in air), while 
lateral  scanning  varied  from  0.5  to  2  mm.  The  system’s  measured  axial  and  transverse 
resolution were ~12 µm and ~15 µm (in air), respectively. 
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Fig. 2. The schematic outline of the SS-OCT system used in this study (ADC: analog to digital 
converter; MZI: Mach Zehnder interferometer). 
2.2 Micro-retroreflectors 
Linear micro-retroreflector arrays were fabricated as follows. A silicon wafer was coated with 
a 5 µm layer of polyimide, a 300 nm layer of poly(methyl glutarimide) (PMGI), and a 200 nm 
layer of poly(methyl-methacrylate) (PMMA) by spin-casting. The top PMMA layer was then 
exposed using electron beam lithography in the pattern of the retroreflectors, developed for 30 
seconds in a 3:1 solution of isopropanol and methylisobutylketone, and rinsed in isopropanol. 
The PMGI layer was then etched in a 2.3% solution of tetramethyl ammonium hydroxide in 
water and a thin coating of nickel was then thermally evaporated onto the wafer surface. A 
lift-off step then dissolved the PMMA leaving only the nickel deposited in the resist openings. 
This pattern was further transferred into the polyimide by a directional oxygen reactive-ion 
etch.  Finally,  the  entire  structure  was  coated  with  a  layer  of  gold.  These  structures  were 
imaged with Scanning Electron Microscopy (SEM), and are shown in Fig. 3. 
Micro-retroreflectors were 5 µm tall, 10 µm wide and 50 µm long. These linear micro-
retroreflectors were designed to reflect light incident from any angle back to the source in an 
anti-parallel  manner.  The  degree  of  alignment  for  linear  micro-retroreflectors  lies  in  one 
angular dimension, as shown in Fig. 1. 
 
Fig. 3. SEM images of micro-retroreflector structures. 
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Whole milk (with 3.7% fat content) and fresh porcine skin were used for testing SS-OCT 
imaging of micro-retroreflectors as a function of the scattering media depth. Porcine skin was 
purchased from the local market. Small skin samples (0.5 × 0.5 cm
2) were excised from the 
porcine ear and placed in a saline bath. The samples were kept hydrated while covering the 
micro-retroreflectors during SS-OCT imaging, and each sample was used only once. 
3. Results 
A  silicon  wafer  containing  gold  micro-retroreflectors  was  mounted  on  top  of  a  dual-axis 
rotating stage, which was further connected to a 2D-translational stage for 3D positioning. 
The  focused  incident  light  beam  from  the  SS-OCT  setup  was  directed  onto  the  micro-
retroreflectors and scanned over a 1 × 1 mm
2 area, an area sufficient for imaging the full 
micro-retroreflector array. At a 65° tilt angle, which provided maximum reflectivity for the 
fabricated  micro-retroreflectors,  3D  sample  volumes  were  recorded  by  SS-OCT  and 
reconstructed using LabVIEW and Thorlabs Swept 3D Viewer software. For each 3D volume, 
multiple  rows  of  micro-retroreflectors  were  averaged  together  to  create  one  1D  micro-
retroreflector intensity profile. Figure 4A shows an example of a recorded 3D volume of 
micro-retroreflectors in air obtained after reconstruction of SS-OCT data, and Fig. 4B displays 
the average intensity profiles obtained within this 3D volume. The average intensity profile 
shown  in  Fig.  4B  was  constructed  by  averaging  together  each  individual  row  of  micro-
retroreflectors displayed in Fig. 4A. B-scans were extracted from each 3D volume and peak 
analysis was performed. The retroreflectors were oriented with the scanning OCT beam such 
that  scanning  occurred  parallel  to  the  retroreflectors.  This  regime  ensured  the  highest 
probability of equivalent reflectivity for all micro-retroreflectors. 
To  investigate  the  ability  of  SS-OCT  to  detect  the  entire  micro-retroreflector  pattern 
within scattering media as a function of depth, two sets of experiments were performed: one 
with whole milk and the other with porcine skin. In the first set of experiments, 21 different 
volumes of whole milk (with 3.7% fat content) were deposited, dropwise, on top of the micro-
retroreflector array to provide different thicknesses of scattering medium. To prevent milk 
spillage, a plastic dam was designed and placed on the silicon wafer with adhesive glue. The 
varied depths of whole milk (refractive index, n = 1.35 [24], ) were determined optically by 
SS-OCT after performing the experiments. Figure 5 represents typical one-dimensional micro-
retroreflector intensity profiles for a selected set of samples with thicknesses ranging from 
0.10 mm to 1.65 mm. 
 
Fig. 4. (A) 3D volume (0.7 mm × 0.7 mm × 3 mm) of micro-retroreflectors in air obtained by 
SS-OCT with row indexing; (B) an averaged intensity profile of micro-retroreflectors in air 
(corresponding to an averaging through rows 1-5 of the micro-retroreflectors shown in A). 
As expected, with an increase in sample depth the contrast between micro-retroreflectors 
and the background medium begins to decrease. Below the depth of 1.65 mm some micro-
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platform pattern. One can see from this figure irregularities in uniformity of the selected peaks 
as  the  sample  depth  increases.  This  observation  can  be  explained  by  the  presence  of 
inhomogeneities in whole milk, such as aggregates of fat globules and of protein particles 
[24]. Similar results were obtained for the remaining sets of samples, and are summarized in 
Fig. 6. 
In the second set of experiments, a 0.5 × 0.5 cm
2 section of porcine skin was excised from 
porcine  ear  and  placed  in  a  saline  bath  to  prevent  dehydration  and  to  preserve  natural 
physiological conditions; 27 samples with thicknesses varying from 0.29 mm to 0.91 mm 
were used. Porcine tissue thicknesses were determined optically from SS-OCT images using 
the known refractive index (n = 1.45 [25], ). Each sample was placed on top of the micro-
retroreflectors, and 2D and 3D SS-OCT data sets were recorded. Figure 7 shows the micro-
retroreflector intensity profiles for porcine tissue depths of 0.31 mm, 0.34 mm, 0.49 mm, 0.59 
mm, 0.61 mm, and 0.80 mm. 
In  the  case  of  porcine  skin,  below  the  depth  of  0.91  mm  some  micro-retroreflectors 
become  undetectable  by  SS-OCT.  Figure  8  summarizes  the  contrast  between  micro-
retroreflectors and porcine tissue for all samples studied in these experiments. 
4. Discussion 
The obtained results demonstrate the capability of SS-OCT to detect micro-retroreflectors 
within highly scattering media, such as whole milk and tissue, at depths up to at least 1.65 
mm.  With  an  increase  in  scattering  media  depth,  the  signal  returning  from  the  micro-
retroreflectors  decreases  due  to  the  attenuation  of  the  photons.  This  reduces  the  contrast 
between the  micro-retroreflectors and  surrounding  media.  Here,  we define contrast as  the 
signal  difference  between  micro-retroreflectors  and  media,  excluding  reflections  returning 
from  tissue  inhomogeneities,  when  the  entire  platform  pattern  remains  fully  visible.  The 
background signal (scattered photons from surrounding media) was averaged and subtracted 
from an averaged signal from the micro-retroreflector surface, which decreases with depth 
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Fig.  5.  Intensity  profiles  of  micro-retroreflectors  beneath  varying  depths  of  whole  milk. 
Estimated dB contrast is shown in upper right corner of each pane. The 3D SS-OCT volumes 
(1 mm × 1 mm × 3 mm) on the right shows micro-retroreflectors beneath 0.53 mm and 0.84 
mm of whole milk. 
 
Fig. 6. Micro-retroreflector–milk contrast beneath varying depths of whole milk. 
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Fig. 7. Intensity profiles of micro-retroreflectors beneath varying thicknesses of porcine tissue. 
Estimated dB contrast is shown in upper right corner of each pane. The 3D SS-OCT volumes 
(1 mm × 1 mm × 3 mm) on the right show micro-retroreflectors beneath 0.34 mm and 0.49 mm 
of porcine tissue. 
 
Fig. 8. Micro-retroreflector – tissue contrast beneath varying thicknesses of porcine tissue. 
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dB  for  whole  milk  and  20  ±  6.4  dB  for  porcine  tissue.  Below  these  levels,  the  micro-
retroreflector structures were obstructed by tissue inhomogeneities. A maximum penetration 
depth of 2 mm for whole milk and 1.15 mm for porcine tissue was estimated by allowing the 
linear fit line in Fig. 6 and Fig. 8 to intercept the abscissa axis (where the contrast is close to 0 
dB).  From  previous  studies  employing  an  analogous  OCT  setup  it  has  been  shown  that 
approximate penetration depths achievable for porcine tissue is about 1 mm, which is in good 
accordance with our results [26]. 
Optical properties are different for homogeneous and heterogeneous media, and contrast 
between the micro-retroreflectors and surrounding media can vary greatly depending on the 
scattering  nature  of  the  media.  Biological  tissue  can  be  described  optically  as  a  spatial 
distribution of refractive indices on the microscopic scale [27,28]. The local refractive index 
within the tissue can range from 1.34 to 1.50, depending on the type of biological tissue. This 
variation (mismatch) of refractive index distribution within the tissue can cause strong light 
scattering. On the other hand, whole  milk can be described as a homogenous solution of 
scattering  centers  (fat  aggregates  and  protein  aggregates)  with  sizes  ranging  from  the 
nanometer to sub-micrometer scale [24]. In contrast to whole milk, porcine tissue has a highly 
reflective rough surface and vast heterogeneity (tissue structures ranging from the micrometer 
to sub-millimeter scale) [26]. The necessity to maintain contrast above a certain level in order 
to  distinguish  the  entire  micro-retroreflector  pattern  from  surrounding  media  reduces  the 
maximum depth within which the micro-retroreflectors can be placed in different scattering 
media. 
Overall,  these  results  reveal  the  operational  depths  and  potential  contrast  (micro-
retroreflector  –  tissue)  for  the  micro-retroreflector-based  platform  immersed  in  scattering 
media, such as biological tissue. It is important to reiterate that the operational depths for the 
envisioned platform are less than the known penetration depths achievable by OCT, due to 
necessity to provide complete pattern visibility. This therefore makes our work essential for 
understanding the depths at which the entire micro-retroreflector-based platform can be placed 
in  highly  scattering  media  before  reflections  are  lost,  which  is  necessary  for  the  future 
development of micro-retroreflector based technologies that operate in the dermis tissue layer. 
5. Conclusion 
Our experimental results demonstrate the possibility of  using OCT for the depth-resolved 
imaging  and  detection  of  micro-retroreflectors  in  skin,  at  depths  reaching  the 
dermis/subcutaneous fat layers. For this study, micro-retroreflectors were chosen because of 
their ability to direct incident light back to the detector in an anti-parallel manner. Incident 
light not directed onto the micro-retroreflectors will scatter in all directions with negligible 
amounts returning to the detector, thereby allowing for contrast to develop between the micro-
retroreflectors and scattering medium. This characteristic makes imaging flat gold mirrors 
challenging, where it is required that the incident light beam be perpendicular to the sample 
surface  in  order  to  obtain  maximal  reflections.  We  have  shown  that  the  proposed  micro-
retroreflector-based platform can be detected with OCT at depths reaching 1.65 mm in whole 
milk and 0.91 mm in porcine tissue, which is generally less than maximum penetration depths 
achievable by OCT. This difference in depth is due to the necessity to provide sufficient 
contrast between the micro-retroreflector-based platform and surrounding scattering media. 
The minimum contrast was found to be 15 ± 3.4 dB for whole milk and 20 ± 6.4 dB for 
porcine  tissue.  High  levels  of  minimum  contrast  for  porcine  tissue  and  whole  milk  are 
suggested to exist due to the presence of inhomogeneities in biological samples, which can 
obstruct  the  reflectivity  of  micro-retroreflector  surfaces  at  greater  depths.  With  further 
development  of  this  assay  platform,  it  may  be  possible  to  utilize  OCT  and  micro-
retroreflectors  as  a  tool  for monitoring  glucose  levels  and  other  analytes  in  subcutaneous 
tissue environments by decorating the micro-retroreflector surface with chemical compounds 
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(C) 2010 OSA 1 September 2010 / Vol. 1,  No. 2 / BIOMEDICAL OPTICS EXPRESS  376selectivity  sensitive  to  certain  analytes,  which  can  then  alter  surface  reflectivity  due  to 
changes in analyte concentration. 
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